In an interview with CancerNetwork®, Eran Ben-Ayre, MD, spoke about guidelines for clinicians treating patients by way of telehealth during the pandemic, and how they can be adapted for future practices.
CancerNetwork® spoke with Debra Patt, MD, PhD, MBA, about the role of telehealth in caring for patients with cancer during the COVID-19 pandemic and beyond.
The Association for Clinical Oncology cites expanded patient access and health equity as reasons for implementing broader telehealth coverage across the United States.
Treatment care changed in the face of the COVID-19 pandemic as necessary virtual visits are proving to be more comfortable and safer for many Veteran patients and survivors of cancer.
The results of a study on telehealth give insight into both the potential barriers and possible benefits of these services, which have been widely utilized since the start of the COVID-19 pandemic.
The expert in urologic oncology spoke about new innovations that he believes will aid in treating patients with urologic cancers.
An expert in urologic oncology seeks to answer further questions regarding the use of telemedicine for this patient population.
Study results revealed the impact of a rurally focused telemedicine program on patient outcomes.
The study was designed to determine the impact of a rurally focused telemedicine program on patient outcomes.
This study revealed that reliability, or patient interpretation of telemedicine as a substitute for in-person visits, of the platform was of the greatest concern to all patients.